Related Experiment Video

Updated: May 5, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K

[Differential diagnosis and common pathology between Alzheimer's disease and vascular dementia]

Hidekazu Tomimoto1

  • 1Department of Neurology, Mie University Graduate School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|December 3, 2013
PubMed

Insights

Mixed dementia, involving Alzheimer's disease (AD) and cerebrovascular disease (CVD), shares overlapping pathologies. Understanding these commonalities is crucial for accurately differentiating between AD and vascular dementia.

Area of Science:

  • Neurology and Neurodegenerative Diseases
  • Cerebrovascular Health

Context:

  • Dementia diagnosis often involves distinguishing between Alzheimer's disease (AD) and vascular dementia (VaD).
  • Mixed dementia, characterized by the coexistence of AD and cerebrovascular disease (CVD), presents diagnostic challenges.

Purpose:

  • To elucidate the pathological overlaps between Alzheimer's disease (AD) and cerebrovascular disease (CVD) in the context of dementia.
  • To highlight the significance of these shared pathologies for the differential diagnosis of mixed dementia.

Summary:

  • Mixed dementia results from the combined effects of Alzheimer's disease (AD) and cerebrovascular disease (CVD).
  • Cerebral amyloid angiopathy, common in AD, can lead to microbleeds and microinfarctions, contributing to vascular dementia.
  • Distinguishing between AD and VaD requires recognizing shared and overlapping pathological features.

Impact:

  • Improved diagnostic accuracy for mixed dementia, leading to more targeted treatment strategies.
  • Enhanced understanding of the complex interplay between neurodegenerative and vascular pathologies in cognitive decline.
  • Potential for earlier and more precise identification of dementia subtypes.

More Related Videos

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.3K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

41.0K

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
693
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K